Complexity of astrocyte-motor neuron interactions in amyotrophic lateral sclerosis

Neurodegenerative Diseases

Volumn 2, Issue 3-4, 2006, Pages 139-146

  Pehar, Mariana ^a   Vargas, Marcelo R ^a   Cassina, Patricia ^b   Barbeito, Ana G ^b   Beckman, Joseph S ^c   Barbeito, Luis ^a  

^a INSTITUTO DE INVESTIGACIONES BIOLÓGICAS CLEMENTE ESTABLE   (Uruguay)

^b DEPARTAMENTO DE BIOQUÍMICA   (Uruguay)

^c OREGON STATE UNIVERSITY   (United States)

Author keywords

Amyotrophic lateral sclerosis; Astrocytes; Fibroblast growth factor; Motor neurons; Nerve growth factor

Indexed keywords

ANTIOXIDANT; COPPER ZINC SUPEROXIDE DISMUTASE; CRYOPROTECTIVE AGENT; FIBROBLAST GROWTH FACTOR 1; FIBROBLAST GROWTH FACTOR RECEPTOR 1; GLUTATHIONE; HEME OXYGENASE 1; NERVE GROWTH FACTOR; PROTEIN P75; TRANSCRIPTION FACTOR NRF2;

AMYOTROPHIC LATERAL SCLEROSIS; ASTROCYTE; CELL ACTIVATION; CELL INTERACTION; CELL PROLIFERATION; CELL SURVIVAL; CELL TYPE; CORD BLOOD STEM CELL TRANSPLANTATION; CYTOTOXICITY; GENE MUTATION; GLIA CELL; HEMATOPOIETIC STEM CELL TRANSPLANTATION; HUMAN; MOTONEURON; NERVE CELL DEGENERATION; NERVE CELL LESION; NERVOUS SYSTEM INFLAMMATION; NEUROTOXICITY; NONHUMAN; PATHOGENESIS; PHENOTYPE; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN SECRETION; REVIEW; SIGNAL TRANSDUCTION;

AMYOTROPHIC LATERAL SCLEROSIS; ANIMALS; ASTROCYTES; CELL COMMUNICATION; CELL DEATH; FIBROBLAST GROWTH FACTOR 1; GLIOSIS; HUMANS; MICE; MOTOR NEURONS; NERVE GROWTH FACTOR; SUPEROXIDE DISMUTASE;

EID: 33744785457     PISSN: 16602854     EISSN: 16602862     Source Type: Journal    
DOI: 10.1159/000089619     Document Type: Review

References (100)

1. Beckman JS, Estévez AG, Crow JP, Barbeito L: Superoxide dismutase and the death of motoneurons in ALS. Trends Neurosci 2001;24:S15-S20.
2. Cleveland DW, Liu J: Oxidation versus aggregation - how do SOD1 mutants cause ALS? Nat Med 2000;6:1320-1321.
3. Pramatarova A, Laganiere J, Roussel J, Brisebois K, Rouleau GA: Neuron-specific expression of mutant superoxide dismutase-1 in transgenic mice does not lead to motor impairment. J Neurosci 2001;21:3369-3374.
4. Clement AM, Nguyen MD, Roberts EA, Garcia ML, Boille S, Rule M, McMahon AP, Doucette W, Siwek D, Ferrante RJ, Brown RH, Julien JP, Goldstein SS, Cleveland DW: Wild-type nonneuronal cells extend survival of SOD1 mutant motor neurons in ALS mice. Science 2003;302:113-117.
5. Bezzi P, Volterra A: A neuron-glia signalling network in the active brain. Curr Opin Neurobiol 2001;11:387-394.
6. Fedoroff S, Vernadakis A (eds): Astrocytes: Biochemistry, Physiology, and Pharmacology of Astrocytes. Orlando, Academic Press, 1986, vol 2, p 420.
7. Dong Y, Benveniste EN: Immune function of astrocytes. Glia 2001;36:180-190.
8. Ridet JL, Malhotra SK, Privat A, Gage FH: Reactive astrocytes: cellular and molecular cues to biological function. Trends Neurosci 1997;20:570-577.
9. Von Bernhardi R, Eugenõn J: Microglial reactivity to β-amyloid is modulated by astrocytes and prointlammatory factors. Brain Res 2004;1025:186-193.
10. Cleveland DW, Rothstein JD: From Charcot to Lou Gehrig: deciphering selective motor neuron death in ALS. Nat Rev Neurosci 2001;2:806-819.
11. Rowland LP, Shneider NA: Amyotrophic lateral sclerosis. N Engl J Med 2001;344:1688-1700.
12. McGeer PL, McGeer EG: Inflammatory processes in amyotrophic lateral sclerosis. Muscle Nerve 2002;26:459-470.
13. Barbeito LH, Pehar M, Cassina P, Vargas MR, Peluffo H, Viera L, Estevez AG, Beckman JS: A role for astrocytes in motor neuron loss in amyotrophic lateral sclerosis. Brain Res Brain Res Rev 2004;47:263-274.
14. Ferri A, Nencini M, Casciati A, Cozzolino M, Angelini DF, Longone P, Spalloni A, Rotilio G, Carri MT: Cell death in amyotrophic lateral sclerosis: interplay between neuronal and glial cells. FASEB J 2004;18:1261-1263.
15. Hirano A: Neuropathology of ALS: an overview, Neurology 1996;47:S63-S66.
16. Kushner PD, Stephenson DI, Wright S: Reactive astrogliosis is widespread in the subcortical white matter of amyotrophic lateral sclerosis brain. J Neuropathol Exp Neurol 1991;50:263-277.
17. Nagy D, Kato T, Kushner PD: Reactive astrocytes are widespread in the cortical gray matter of amyotrophic lateral sclerosis. J Neurosci Res 1994;38:336-347.
18. O'Really SA, Roedica J, Nagy D, Hallewell RA, Alderson K, Marklund JK, Kushner PD: Motor neuron-astrocyte interactions and levels of Cu,Zn superoxide dismutase in sporadic amyotrophic lateral sclerosis. Exp Neurol 1995;131:203-210.
19. Schipper HM: Astrocytes, brain aging, and neurodegeneration. Neurobiol Aging 1996;17:467-480.
20. Migheli A, Cordera S, Bendotti C, Atzori C, Piva R, Schiffer D: S-100β protein is upregulated in astrocytes and motor neurons in the spinal cord of patients with amyotrophic lateral sclerosis. Neurosci Lett 1999;261:25-28.
21. Maihofner C, Probst-Cousin S, Bergmann M, Neuhuber W, Neundorfer B, Heuss D: Expression and localization of cyclooxygenase-1 and -2 in human sporadic amyotrophic lateral sclerosis. Eur J Neurosci 2003;18:1527-1534.
22. Anneser JM, Cookson MR, Ince PG, Shaw PJ, Borasio GD: Glial cells of the spinal cord and subcortical white matter up-regulate neuronal nitric oxide synthase in sporadic amyotrophic lateral sclerosis. Exp Neurol 2001;171:418-421.
23. Sasaki S, Shibata N, Komori T, Iwata M: iNOS and nitrotyrosine immunoreactivity in amyotrophic lateral sclerosis. Neurosci Lett 2000;291:44-48.
24. Abe K, Pan LH, Watanabe M, Konno H, Kato T, Itoyama Y: Upregulation of protein-tyrosine nitration in the anterior horn cells of amyotrophic lateral sclerosis. Neurol Res 1997;19:124-128.
25. Pedersen WA, Fu W, Keller JN, Markesberry WR, Appel SA, Smith RG, Kasarkis E, Mattson MP: Protein modification by the lipid peroxidation product 4-hydroxynonenal in the spinal cords of amyotrophic lateral sclerosis patients. Ann Neurol 1998;44:819-824.
26. Howland DS, Liu J, She Y, Goad B, Maragakis NJ, Kim B, Erickson J, Kulik J, DeVito L, Psaltis G, DeGennaro LJ, Cleveland DW, Rothstein JD: Focal loss of the glutamate transporter EAAT2 in a transgenic rat model of SOD1 mutant-mediated amyotrophic lateral sclerosis. Proc Natl Acad Sci USA 2002;99:1604-1609.
27. Huber K, Meisinger C, Grothe C: Expression of fibroblast growth factor-2 in hypoglossal motoneurons is stimulated by peripheral nerve injury. J Comp Neurol 1997;382:189-198.
28. Olsson T, Kristensson K, Ljungdahl A, Maehlen J, Holmdahl R, Klareskog L: Gamma-interferon-like immunoreactivity in axotomized rat motor neurons. J Neurosci 1989;9:3870-3875.
29. Krum JM, Mani N, Rosenstein JM: Angiogenic and astroglial responses to vascular endothelial growth factor administration in adult rat brain. Neuroscience 2002;110:589-604.
30. Cassina P, Peluffo H, Pehar M, Martinez-Palma L, Ressia A, Beckman JS, Estévez AG, Barbeito L: Peroxynitrite triggers a phenotypic transformation in spinal cord astrocytes that induces motor neuron apoptosis. J Neurosci Res 2002;67:21-29.
31. Estévez AG, Spear N, Manuel SM, Radi R, Henderson CE, Barbeito L, Beckman JS: Nitric oxide and superoxide contribute to motor neuron apoptosis induced by trophic factor deprivation. J Neurosci 1998;18:923-931.
32. Raoul C, Estevez AG, Nishimune H, Cleveland DW, deLapeyriere O, Henderson CE, Haase G, Pettmann B: Motoneuron death triggered by a specific pathway downstream of Fas. Potentiation by ALS-linked SOD1 mutations. Neuron 2002;35:1067-1083.
33. Estévez AG, Crow JP, Sampson JB, Reiter C, Zhuang Y, Richardson GJ, Tarpey MM, Barbeito L, Beckman JS: Induction of nitric oxide-dependant apoptosis in motor neurons by zinc-deficient superoxide dismutase. Science 1999;286:2498-2500.
34. Ornitz DM, Itoh N: Fibroblast growth factor. Reviews. Genome Biol 2001;2:3005.
35. Elde R, Cao YH, Cintra A, Brelje TC, Pelto-Huikko M, Junttila T, Fuxe K, Pettersson RF, Hokfelt T: Prominent expression of acidic fibroblast growth factor in motor and sensory neurons. Neuron 1991;7:349-364.
36. Eckenstein FP: Fibroblast growth factors in the nervous system. J Neurobiol 1994;25:1467-1480.
37. Kresse A, Pettersson R, Hokfelt T: Distribution of acidic fibroblast growth factor mRNA-expressing neurons in the adult mouse central nervous system. J Comp Neurol 1995;359:323-339.
38. Piehl F, Arvidsson U, Johnson H, Cullheim S, Dagerlind A, Ulfhake B, Cao Y, Elde R, Pettersson RF, Terenius L, et al: GAP-43, aFGF, CCK and α- and β-CGRP in rat spinal motoneurons subjected to axotomy and/or dorsal root severance. Eur J Neurosci 1993;5:1321-1333.
39. Koshinaga M, Sanon HR, Whittemore SR: Altered acidic and basic fibroblast growth factor expression following spinal cord injury. Exp Neurol 1993;120:32-48.
40. Mouta Carreira C, Landriscina M, Bellum S, Prudovsky I, Maciag T: The comparative release of FGF1 by hypoxia and temperature stress. Growth Factors 2001;18:277-285.
41. Opalenik SR, Ding Q, Mallery SR, Thompson JA: Glutathione depletion associated with the HIV-1 TAT protein mediates the extracellular appearance of acidic fibroblast growth factor. Arch Biochem Biophys 1998;351:17-26.
42. Bagnasco P, MacMillan-Crow LA, Greendorfer JS, Young CJ, Andrews L, Thompson JA: Peroxynitrite modulates acidic fibroblast growth factor (FGF-1) activity. Arch Biochem Biophys 2003;419:178-189.
43. Cassina P, Pehar M, Vargas MR, Castellanos R, Barbeito AG, Estevez AG, Thompson JA, Beckman JS, Barbeito L: Astrocyte activation by fibroblast growth factor-1 and motor neuron apoptosis: implications for amyotrophic lateral sclerosis. J Neurochem 2005;93:38-46.
44. Burke D, Wilkes D, Blundell TL, Malcolm S: Fibroblast growth factor receptors: Lessons from the genes. Trends Biochem Sci 1998;23:59-62.
45. Stachowiak EK, Maher PA, Tucholski J, Mordechai E, Joy A, Moffett J, Coons S, Stachowiak MK: Nuclear accumulation of fibroblast growth factor receptors in human glial cells - association with cell proliferation. Oncogene 1997;14:2201-2211.
46. Clarke WE, Berry M, Smith C, Kent A, Logan A: Coordination of fibroblast growth factor receptor 1 (FGFR1) and fibroblast growth factor-2 (FGF-2) trafficking to nuclei of reactive astrocytes around cerebral lesions in adult rats. Mol Cell Neurosci 2001;17:17-30.
47. Stachowiak MK, Fang X, Myers JM, Dunham SM, Berezney R, Maher PA, Stachowiak EK: Integrative nuclear FGFR1 signaling as a part of a universal 'feed-forward-and-gate' signaling module that controls cell growth and differentiation. J Cell Biochem 2003;90:662-691.
48. Cuevas P, Carceller F, Gimenez-Gallego G: Acidic fibroblast growth factor prevents death of spinal cord motoneurons in newborn rats after nerve section. Neurol Res 1995;17:396-399.
49. Laird JM, Mason GS, Thomas KA, Hargreaves RJ, Hill RG: Acidic fibroblast growth factor stimulates motor and sensory axon regeneration after sciatic nerve crush in the rat. Neuroscience 1995;65:209-216.
50. Teng YD, Mocchetti I, Wrathall JR: Basic and acidic fibroblast growth factors protect spinal motor neurones in vivo after experimental spinal cord injury. Eur J Neurosci 1998;10:798-802.
51. Vargas MR, Pehar M, Cassina P, Martinez-Palma L, Thompson JA, Beckman JS, Barbeito L: Fibroblast growth factor-1 induces heme oxygenase-1 via nuclear factor erythroid 2-related factor 2 in spinal cord astrocytes: consequences for motor neuron survival. J Biol Chem 2005;280:25571-25579.
52. Shih AY, Johnson DA, Wong G, Kraft AD, Jiang L, Erb H, Johnson JA, Murphy TH: Coordinate regulation of glutathione biosynthesis and release by Nrf2-expressing glia potently protects neurons from oxidative stress. J Neurosci 2003;23:3394-3406.
53. Kraft AD, Johnson DA, Johnson JA: Nuclear factor erythroid 2-related factor 2-dependent antioxidant response element activation by tert-butylhydroquinone and sulforaphane occurring preferentially in astrocytes conditions neurons against oxidative insult. J Neurosci 2004;24:1101-1112.
54. Maines MD: Heme oxygenase: function, multiplicity, regulatory mechanisms, and clinical applications. FASEB J 1988;2:2557-2568.
55. Stocker R, Yamamoto Y, McDonagh AF, Glazer AN, Ames BN: Bilirubin is an antioxidant of possible physiological importance. Science 1987;235:1043-1046.
56. Dore S, Takahashi M, Ferris CD, Zakhary R, Hester LD, Guastella D, Snyder SH: Bilirabin, formed by activation of heme oxygenase-2, protects neurons against oxidative stress injury. Proc Natl Acad Sci USA 1999;96:2445-2450.
57. Baranano DE, Rao M, Ferris CD, Snyder SH: Biliverdin reductase: a major physiologic cyto-protectant. Proc Natl Acad Sci USA 2002;99:16093-16098.
58. Shibahara S, Muller R, Taguchi H, Yoshida T: Cloning and expression of cDNA for rat heme oxygenase. Proc Natl Acad Sci USA 1985;82:7865-7869.
59. Maines MD, Trakshel GM, Kutty RK: Characterization of two constitutive forms of rat liver microsomal heme oxygenase. Only one molecular species of the enzyme is inducible. J Biol Chem 1986;261:411-419.
60. Ewing JF, Haber SN, Maines MD: Normal and heat-induced patterns of expression of heme oxygenase-1 (HSP32) in rat brain: hyperthermia causes rapid induction of mRNA and protein. J Neurochem 1992;58:1140-1149.
61. Ewing JF, Maines MD: Rapid induction of heme oxygenase 1 mRNA and protein by hyperthermia in rat brain: heme oxygenase 2 is not a heat shock protein. Proc Natl Acad Sci USA 1991;88:5364-5368.
62. Dwyer BE, Nishimura RN, Lu SY: Differential localization of heme oxygenase and NADPH-diaphorase in spinal cord neurons. Neuroreport 1995;6:973-976.
63. Dwyer BE, Nishimura RN, De Vellis J, Yoshida T: Heme oxygenase is a heat shock protein and PEST protein in rat astroglial cells. Glia 1992;5:300-305.
64. Dwyer BE, Nishimura RN, Lu SY: Differential expression of heme oxygenase-1 in cultured cortical neurons and astrocytes determined by the aid of a new heme oxygenase antibody. Response to oxidative stress. Brain Res Mol Brain Res 1995;30:37-47.
65. Kitamura Y, Furukawa M, Matsuoka Y, Tooyama I, Kimura H, Nomura Y, Taniguchi T: In vitro and in vivo induction of heme oxygenase-1 in rat glial cells: possible involvement of nitric oxide production from inducible nitric oxide synthase. Glia 1998;22:138-148.
66. Schipper HM, Bernier L, Mehindate K, Frankel D: Mitochondrial iron sequestration in dopamine-challenged astroglia: role of heme oxygenase-1 and the permeability transition pore. J Neurochem 1999;72:1802-1811.
67. Regan RF, Guo Y, Kumar N: Heme oxygenase-1 induction protects murine cortical astrocytes from hemoglobin toxicity. Neurosci Lett 2000;282:1-4.
68. Mehindate K, Sahlas DJ, Frankel D, Mawal Y, Liberman A, Corcos J, Dion S, Schipper HM: Proinflammatory cytokines promote glial heme oxygenase-1 expression and mitochondrial iron deposition: implications for multiple sclerosis. J Neurochem 2001;77:1386-1395.
69. Fauconneau B, Petegnief V, Sanfeliu C, Piriou A, Planas AM: Induction of heat shock proteins by sodium arsenite in cultured astrocytes and reduction of hydrogen peroxide-induced cell death. J Neurochem 2002;83:1338-1348.
70. Poss KD, Tonegawa S: Reduced stress defense in heme oxygenase 1-deficient cells. Proc Natl Acad Sci USA 1997;94:10925-10930.
71. Yachie A, Niida Y, Wada T, Igarashi N, Kaneda H, Toma T, Ohta K, Kasahara Y, Koizumi S: Oxidative stress causes enhanced endothelial cell injury in human heme oxygenase-1 deficiency. J Clin Invest 1999;103:129-135.
72. Chen K, Gunter K, Maines MD: Neurons overexpressing heme oxygenase-1 resist oxidative stress-mediated cell death. J Neurochem 2000;75:304-313.
73. Schipper HM: Heme oxygenase expression in human central nervous system disorders. Free Radic Biol Med 2004;37:1995-2011.
74. Yoshida K, Gage FH: Fibroblast growth factors stimulate nerve growth factor synthesis and secretion by astrocytes. Brain Res 1991;538:118-126.
75. Ono T, Saito H, Kishimoto T, Okumoto T, Miyamoto K: Stimulation of biosynthesis of nerve growth factor by acidic fibroblast growth factor in cultured mouse astrocytes. Neurosci Lett 1991;126:18-20.
76. Nykjaer A, Willnow TE, Petersen CM: p75NTR - live or let die. Curr Opin Neurobiol 2005;15:49-57.
77. Majdan M, Miller F: Neuronal life and death decisions: functional antagonism between the Trk and p75 neurotrophin receptors. Int J Dev Neurosci 1999;17:153-161.
78. Levi-Montalcini R, Skaper SD, Dal Toso R, Petrelli L, Leon A: Nerve growth factor: from neurotrophin to neurokine. Trends Neurosci 1996;19:514-520.
79. Pehar MA, Cassina MP, Vargas MR, Castellanos RM, Viera L, Beckman JS, Estevez AG, Barbeito L: Astrocytic production of nerve growth factor and motor neuron apoptosis: implications for amyotrophic lateral sclerosis. J Neurochem 2004;89:464-473.
80. Raoul C, Pettmann B, Henderson CE: Active killing of neurons during development and following stress: a role for p75(NTR) and Fas? Curr Opin Neurobiol 2000;10:111-117.
81. Merrill JE, Scolding NJ: Mechanisms of damage to myelin and oligodendrocytes and their relevance to disease. Neuropathol Appl Neurobiol 1999;25:435-458.
82. Ernfors P, Henschen A, Olson L, Persson H: Expression of nerve growth factor receptor mRNA is developmentally regulated and increased after axotomy in rat spinal cord motoneurons. Neuron 1989;2:1605-1613.
83. Urschel BA, Hulsebosch CE: Distribution and relative density of p75 nerve growth factor receptors in the rat spinal cord as a function of age and treatment with antibodies to nerve growth factor. Brain Res Dev Brain Res 1992;69:261-270.
84. Yan Q, Johnson EM Jr: An immunohistochemical study of the nerve growth factor receptor in developing rats. J Neurosci 1988;8:3481-3498.
85. Ferri CC, Moore FA, Bisby MA: Effects of facial nerve injury on mouse motoneurons lacking the p75 low-affinity neurotrophin receptor. J Neurobiol 1998;34:1-9.
86. Koliatsos VE, Crawford TO, Price DL: Axotomy induces nerve growth factor receptor immunoreactivity in spinal motor neurons. Brain Res 1991;549:297-304.
87. Rende M, Giambanco I, Buratta M, Tonali P: Axotomy induces a different modulation of both low-affinity nerve growth factor receptor and choline acetyltransferase between adult rat spinal and brainstem motoneurons. J Comp Neurol 1995;363:249-263.
88. Wu W: Potential roles of gene expression change in adult rat spinal motoneurons following axonal injury: a comparison among c-jun, off-affinity nerve growth factor receptor, and nitric oxide synthase. Exp Neurol 1996;141:190-200.
89. Wiese S, Metzger F, Holtmann B, Sendtner M: The role of p75NTR in modulating neurotrophin survival effects in developing motoneurons. Eur J Neurosci 1999;11:1668-1676.
90. Lowry KS, Murray SS, McLean CA, Talman P, Mathers S, Lopes EC, Cheema SS: A potential role for the p75 low-affinity neurotrophin receptor in spinal motor neuron degeneration in murine and human amyotrophic lateral sclerosis. Amyotroph Lateral Scler Other Motor Neuron Disord 2001;2:127-134.
91. trkB mRNA in amyotrophic lateral sclerosis. Brain Res 1993;621:111-115.
92. Namiki J, Tator CH: Cell proliferation and nest in expression in the ependyma of the adult rat spinal cord after injury. J Neuropathol Exp Neurol 1999;58:489-498.
93. Lang B, Liu HL, Liu R, Feng GD, Jiao XY, Ju G: Astrocytes in injured adult rat spinal cord may acquire the potential of neural stem cells. Neuroscience 2004;128:775-783.
94. Chi L, Ke Y, Luo C, Gozal D, Liu R: Neural stem cell proliferation, migration and differentiation in an ALS-like mouse model. Free Radic Biol Med 2004;37:S157.
95. Iwanami A, Kaneko S, Nakamura M, Kanemura Y, Mori H, Kobayashi S, Yamasaki M, Momoshima S, Ishii H, Ando K, Tanioka Y, Tamaoki N, Nomura T, Toyama Y, Okano H: Transplantation of human neural stem cells for spinal cord injury in primates. J Neurosci Res 2005;80:182-190.
96. Chen R, Ende N: The potential for the use of mononuclear cells from human umbilical cord blood in the treatment of amyotrophic lateral sclerosis in SOD1 mice. J Med 2000;31:21-30.
97. Garbuzova-Davis S, Willing AE, Zigova T, Saporta S, Justen EB, Lane JC, Hudson JE, Chen N, Davis CD, Sanberg PR: Intravenous administration of human umbilical cord blood cells in a mouse model of amyotrophic lateral sclerosis: distribution, migration, and differentiation. J Hematother Stem Cell Res 2003;12:255-270.
98. Corti S, Locatelli F, Donadoni C, Guglieri M, Papadimitriou D, Strazzer S, Del Bo R, Comi GP: Wild-type bone marrow cells ameliorate the phenotype of SOD1-G93A ALS mice and contribute to CNS, heart and skeletal muscle tissues. Brain 2004;127:2518-2532.
99. Weydt P, Yuen EC, Ransom BR, Moller T: Increased cytotoxic potential of microglia from ALS-transgenic mice. Glia 2004;48:179-182.
100. Von Bernhardi R, Eugenín J: Microglial reactivity to β-amyloid is modulated by astrocytes and proinflammatory factors. Brain Res 2004;1025:186-193.